SCHEMBL9955148

SCHEMBL9955148

CCCCCCCC/C=C\CCCCCCC(C(=O)O)C(O)CC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 2/20 0.52
FFAR4 Q5NUL3 1/20 0.52
PPARG P37231 4/20 0.50
TERT O14746 3/20 0.50
PTPN1 P18031 3/20 0.50
PPARD Q03181 3/20 0.50
PPARA Q07869 3/20 0.50
TOP1 P11387 3/20 0.50
MAPT P10636 2/20 0.50
BLM P54132 2/20 0.50
HSD17B10 Q99714 2/20 0.50
FABP4 P15090 2/20 0.50
GMNN O75496 1/20 0.50
USP2 O75604 1/20 0.50
LMNA P02545 1/20 0.50
CYP1A2 P05177 1/20 0.50
POLB P06746 1/20 0.50
CYP2C9 P11712 1/20 0.50
ALOX15 P16050 1/20 0.50
APEX1 P27695 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8897518 0.92 FFAR1 (0.54) FFAR1FFAR4PPARGTERTPTPN1
SCHEMBL12557255 0.92 FFAR1 (0.54) FFAR1FFAR4PPARGTERTPTPN1
SCHEMBL8897515 0.92 FFAR1 (0.54) FFAR1FFAR4PPARGTERTPTPN1
SCHEMBL27525132 0.92 FFAR1 (0.54) FFAR1FFAR4PPARGTERTPTPN1
SCHEMBL28525482 0.90 GPR84 (0.59) FFAR1FFAR4PPARDMAPTGPR84
SCHEMBL9396585 0.90 GPR84 (0.59) FFAR1FFAR4PPARDMAPTGPR84
SCHEMBL9559491 0.90 GPR84 (0.59) FFAR1FFAR4PPARDMAPTGPR84
SCHEMBL28500830 0.90 GPR84 (0.59) FFAR1FFAR4PPARDMAPTGPR84
SCHEMBL5168520 0.90 GPR84 (0.59) FFAR1FFAR4PPARDMAPTGPR84
SCHEMBL30413590 0.86 ALDH1A1 (0.54) FFAR1FFAR4PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2654665-A2 METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY MIKA Pharma Gesellschaft für die Entwicklung und Vermarktung pharmazeutischer Produkte mbH (DE) 2013-10-30 EP disclosed
WO-2012083906-A2 METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY MIKA PHARMA GESELLSCHAFT FÜR DIE ENTWICKLUNG UND VERMARKTUNG PHARMAZEUTISCHER PRODUKTE MBH (DE) 2012-06-28 WO disclosed